Aether Biomedical is thrilled to announce a successful funding round of $1.4 million, propelling our mission to redefine healthcare technology and robotics with a human-centered design ethos. Founded with a vision to engineer the next generation of bionic devices, Aether Biomedical has made significant strides in cutting-edge biosignal processing and software integration. Following our expansion throughout Europe and Asia, we are excited to launch our flagship product, the Zeus hand, into the U.S. market, with our new headquarters based in the heart of Chicago, IL.
Zeus represents a groundbreaking advancement in bionic prosthetics, asserting itself as the strongest multi-articulating myoelectric hand in the world. With an impressive grip force of 152 Newtons, it delivers 30-40% more strength than existing solutions, making it a game-changer for users. Its innovative design includes a patent-pending impact resistance mechanism, which ensures the fingers flex upon impact, safeguarding them from breakage—a crucial feature for everyday usability. Furthermore, the Zeus hand breaks new ground with its repairability, allowing for complete repairs in under 15 minutes using standard workshop tools.
In conjunction with the hand, we're developing a comprehensive digital ecosystem of mobile and software applications to enhance patient interaction through real-time analytics and configuration. Users can seamlessly adjust settings via a robust web-based platform, eliminating the need for cumbersome application downloads, and track changes effortlessly. This funding not only fuels our mission to bring Zeus to patients in the U.S. but also reaffirms our commitment to providing truly customizable and high-quality bionic solutions. Aether Biomedical is poised to transform lives, and we are excited for what the future holds!
.png&w=3840&q=75)
